“脑-肠轴”理论指导下针刺治疗卒中后抑郁临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R277.7;R255.2

基金项目:

浙江省中医药科技计划项目(2023ZL507);台州学院医学部青年医生科研与教学专项启动基金项目(YXBY202414)


Clinical Study of Acupuncture in the Treatment of Post-Stroke Depression Under the Guidance of the "Brain-Gut Axis" Theory
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察“脑-肠轴”理论指导下针刺治疗卒中后抑郁(PSD) 的临床疗效。方法:纳入2023年1月—2025年12月在温州医科大学附属第一医院住院的PSD患者78例,采用随机数字表法分为治疗组与对照组各39例,治疗期间治疗组与对照组各脱落3例,最终各完成36例。在常规治疗的基础上,治疗组加用针刺治疗,对照组加用盐酸帕罗西汀片治疗。治疗4周后,观察比较2组抑郁状况[汉密顿抑郁量表(HAMD) 评分、抑郁自评量表(SDS) 评分]、日常生活能力(修订版Barthel指数) 评分、神经功能缺损程度[美国国立卫生研究院卒中量表(NIHSS) 评分]、营养状况[体质量指数(BMI)、红细胞计数、血红蛋白、血清白蛋白、血清前白蛋白] 以及炎症因子[白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、核因子-κB(NF-κB)] 水平。结果:治疗后,治疗组总有效率为94.44%(34/36),对照组为72.22%(26/36),2组比较,差异有统计学意义(P<0.05)。治疗后,2组HAMD、SDS评分均较治疗前降低(P<0.05),且治疗组HAMD、SDS评分均低于对照组(P<0.05)。治疗后,2组NIHSS评分较治疗前降低(P<0.05),Barthel指数评分较治疗前升高(P<0.05);且治疗组NIHSS 评分低于对照组(P<0.05),Barthel 指数评分高于对照组(P<0.05)。治疗后,治疗组BMI、红细胞计数、血红蛋白、血清白蛋白及血清前白蛋白水平均较治疗前升高,且各项指标水平均高于对照组,差异均有统计学意义(P<0.05);对照组上述各项指标水平治疗前后比较,差异无统计学意义(P>0.05)。治疗后,2 组血清IL-1β、IL-6、TNF-α、NF-κB 水平均较治疗前降低(P<0.05),且治疗组各项指标水平均低于对照组(P<0.05)。治疗组不良反应发生率8.33%(3/36),对照组为13.88% (5/36),2组比较,差异无统计学意义(P>0.05)。结论:基于“脑-肠轴”理论针刺治疗PSD可提高临床疗效,有效改善患者的抑郁状态、神经功能缺损程度及营养状况,提高患者日常生活能力,且安全性较好。

    Abstract:

    Abstract:Objective:To observe the clinical efficacy of acupuncture for post-stroke depression (PSD) under the guidance of the "brain-gut axis" theory. Methods: A total of 78 PSD patients hospitalized in the First Affiliated Hospital of Wenzhou Medical University from January 2023 to December 2025 were enrolled. They were divided into a treatment group and a control group using the random number table method, with 39 cases in each group. During treatment,3 cases dropped out from each group,finally,36 cases in each group completed the study. On the basis of conventional treatment, the treatment group received acupuncture, while the control group received Paroxetine Hydrochloride Tablets. After four weeks of treatment, changes in depression [Hamilton Depression Scale (HAMD) score, Self-Rating Depression Scale (SDS) score], activities of daily living [modified Barthel Index (BI) score], neurological deficit [National Institutes of Health Stroke Scale (NIHSS) score],nutrition [Body Mass Index( BMI),red blood cell count, hemoglobin, serum albumin, and serum prealbumin], and levels of inflammatory factors [interleukin-1β (IL-1β),interleukin-6 (IL-6),tumor necrosis factor-α (TNF-α),nuclear factor-κB (NF-κB)] were compared in the two groups. Results: After treatment, the total effective rate was 94.44% (34/36) in the treatment group and 72.22% (26/36) in the control group,and the difference between the two groups was statistically significant( P<0.05). After treatment,the HAMD and SDS scores in both groups decreased compared with those before treatment (P<0.05), and the HAMD and SDS scores in the treatment group were lower than those in the control group (P<0.05). After treatment, the NIHSS scores in both groups decreased compared with those before treatment (P<0.05), while the BI scores increased compared with those before treatment (P<0.05); the NIHSS score in the treatment group was lower than that in the control group (P<0.05),and the BI score was higher than that in the control group (P<0.05). After treatment, the nutritional indicators including BMI, red blood cell count, hemoglobin,serum albumin,and serum prealbumin levels in the treatment group increased compared with those before treatment and were higher than those in the control group,with statistically significant differences (P<0.05);while there were no statistically significant differences in the above indicators in the control group before and after treatment (P>0.05). After treatment, the levels of IL-1β, IL-6, TNF-α, and NF-κB in both groups decreased compared with those before treatment (P<0.05), and the levels of IL-1β, IL-6, TNF- α, and NF- κB in the treatment group were lower than those in the control group (P<0.05). The incidence of adverse reactions was 8.33% (3/36) in the treatment group and 13.88% (5/36) in the control group, and the difference between the two groups was not statistically significant (P>0.05). Conclusion: Acupuncture in the treatment of PSD under the guidance of the "brain-gut axis" theory can enhance clinical efficacy, alleviate depressive symptoms, reduce neurological deficits,improve nutrition and activities of daily living in patients,with favorable safety.

    参考文献
    相似文献
    引证文献
引用本文

贾翔,郭小青,丛文杰.“脑-肠轴”理论指导下针刺治疗卒中后抑郁临床研究[J].新中医,2026,58(20):80-85

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-10-21
  • 出版日期:
文章二维码